Core Viewpoint - Novo Nordisk is experiencing a leadership shake-up as several board members will resign following disagreements with the controlling shareholder regarding the board's future composition [2][3]. Group 1: Board Composition and Changes - The board proposed a renewal that focuses on adding new competencies while maintaining continuity, but the Novo Nordisk Foundation sought a more extensive reconfiguration [2]. - Key board members, including Chair Helge Lund and Vice Chair Henrik Poulsen, will not stand for election at the upcoming Extraordinary General Meeting scheduled for November 14 [3]. Group 2: Market Reaction - Following the announcement, shares of Novo Nordisk traded 1.2% lower as of 1:41 p.m. London time [3].